10-Q: Corvex, Inc. Completes Merger, Shifts Focus to AI Cloud Computing

Corvex, Inc. reports Q1 2026 results following a significant merger, with revenue increasing to $510,000, driven by the new AI platform segment.

Summary

• Corvex, Inc. has completed a merger with Corvex Legacy Holdings, Inc. (Corvex OpCo) on March 19, 2026, and subsequently changed its name from Movano Inc. The company is now focused on two segments: AI Platform and services, and Connected devices and services (healthcare).
• Total revenue for the three months ended March 31, 2026, was $510,000, a significant increase from $206,000 in the prior year period, primarily due to the inclusion of Corvex OpCo's AI Platform and services revenue.
• The company reported a net loss of $5.0 million for the quarter, compared to a net loss of $5.2 million in the same period last year. Adjusted EBITDA improved to a loss of $1.6 million from a loss of $4.9 million.
• Cash and cash equivalents stood at $29.3 million as of March 31, 2026, which management believes is sufficient for at least the next twelve months.
• The company has recognized substantial goodwill ($518.3 million) and intangible assets ($15.4 million) as a result of the merger.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral to slightly positive sentiment, reflecting a significant strategic shift and revenue growth driven by acquisition, but tempered by continued substantial losses and the inherent risks of early-stage AI businesses.

Positives

• Total revenue increased by 148% to $510,000 for the three months ended March 31, 2026, driven by the new AI Platform and services segment.
• The AI Platform and services segment generated $475,000 in revenue, marking the initial contribution from the newly acquired business.
• Loss from operations decreased by 7% to $4.8 million from $5.2 million in the prior year period.
• Adjusted EBITDA improved significantly, with a loss of $1.6 million compared to a loss of $4.9 million in the prior year.
• Cash and cash equivalents increased substantially to $29.3 million from $2.8 million, providing improved liquidity.

Negatives

• The company continues to incur significant net losses, with a loss of $5.0 million for the quarter.
• Revenue from the Connected devices and services segment decreased by 83% to $35,000, reflecting a strategic shift away from the healthcare business.
• Technology and infrastructure expenses increased by 65% to $822,000, largely due to the integration of the acquired AI business.
• General and administrative expenses more than doubled to $3.4 million, driven by merger-related costs and increased stock-based compensation.
• The company has an accumulated deficit of $171.4 million as of March 31, 2026.

Risks

• The company has a limited operating history and has incurred significant operating losses and negative cash flows since inception, with an accumulated deficit of $171.4 million.
• Future profitability is uncertain, and the company expects to continue incurring net losses for the foreseeable future.
• The company's ability to execute its longer-term business plan depends on factors like the pace of infrastructure expansion, customer demand, and cost management.
• There is a risk that the company may not be able to raise additional capital through equity offerings, debt financings, or strategic partnerships on acceptable terms, or at all.
• The company has identified material weaknesses in its internal controls over financial reporting, including an insufficient number of personnel with appropriate knowledge and experience, and ineffective IT general controls.

Future Outlook

The company expects to continue incurring net losses for the foreseeable future as it invests in its AI cloud computing business and maintains its legacy healthcare operations at a reduced capacity. Management believes existing cash and cash equivalents are sufficient for at least the next twelve months, but may seek additional capital through equity or debt offerings to support future growth. The company anticipates increased expenses and capital requirements as it scales its AI business and operates as a public company.

Management Comments

• The Company has been determined to be the accounting acquirer, and accordingly, the financial statements for periods prior to the Merger reflect only the historical results of the Companys legacy healthcare business. The results of operations of Corvex OpCo have been included in the Companys consolidated financial statements beginning on the acquisition date.
• Following the merger, the Company operates with a different business mix, cost structure, and capital requirements, reflecting the early-stage nature of the AI cloud computing business, including increased investment in infrastructure and personnel.
• We believe that our existing cash and cash equivalents will be sufficient to fund our projected operating requirements for at least the next twelve months from the date of issuance of the condensed consolidated financial statements.
• We may seek to raise additional capital through public or private equity offerings, debt financings, or strategic partnerships to support future growth initiatives. However, there can be no assurance that such financing will be available on acceptable terms, or at all.

Industry Context

StockSavvy.ai notes that Corvex's strategic shift towards AI cloud computing, particularly GPU-accelerated infrastructure, aligns with the significant industry trend of increasing demand for AI and machine learning workloads. The acquisition of Corvex OpCo positions the company to capitalize on this growth, while the divestment from the healthcare wearables segment suggests a prioritization of higher-growth, higher-margin opportunities.

Comparison to Industry Standards

• The AI Platform and services segment's revenue of $475,000 for a partial quarter is nascent compared to established cloud infrastructure providers like Amazon Web Services (AWS), Microsoft Azure, or Google Cloud, which generate billions in quarterly revenue.
• Corvex's reported net loss of $5.0 million for the quarter, while significant for its current revenue scale, is not uncommon for early-stage technology companies investing heavily in infrastructure and market penetration, similar to the initial phases of many successful cloud computing startups.
• The company's focus on GPU-accelerated infrastructure for AI workloads places it in a competitive space with specialized providers and major cloud players offering similar services. Benchmarking against these competitors would require detailed performance and pricing comparisons, which are not provided in this filing.
• The healthcare wearables segment's revenue of $35,000 is minimal compared to established players in the consumer wearable market like Apple (Apple Watch) or Fitbit, indicating a strategic decision to de-emphasize this area.

Legal Proceedings

• Management is not currently aware of any legal matters that may have a material adverse impact on the Company's business, financial position, results of operations or cash flows.

Related Party Transactions

• The company has a bridge loan with a related party, which had a carrying amount of $4.5 million as of March 31, 2026. Interest expense related to this loan was $177,000 for the quarter.

Stakeholder Impact

• Shareholders: Potential dilution from future equity offerings, but also potential upside from the AI business growth. The merger significantly changes the company's strategic direction.
• Employees: Increased stock-based compensation expense related to the merger and new equity awards. Potential for growth and new opportunities within the AI segment.
• Creditors: The bridge loan has been amended multiple times, with a maturity date extended to June 30, 2026, and provisions for asset transfer if not repaid. The company's ability to repay is a key consideration.
• Suppliers: Dependence on third-party manufacturers for products and components, with no single supplier accounting for more than 10% of purchases as of March 31, 2026.

Next Steps

• The company will continue to invest in the development and expansion of its AI cloud computing business.
• The company will maintain its legacy healthcare operations in a reduced capacity.
• The company may seek additional capital through equity offerings, debt financings, or strategic partnerships.
• The company will continue to evaluate strategic alternatives and explore transactions to monetize certain legacy assets.
• Stockholder approval is required for the conversion of Series C and Series D Preferred Stock into Common Stock.

Key Dates

Recommendation

The company has undergone a significant transformation with the merger and strategic shift to AI cloud computing, which presents growth potential. However, the substantial ongoing losses, significant accumulated deficit, and identified material weaknesses in internal controls introduce considerable risk. While revenue has increased, it is from a new, early-stage business. A 'hold' recommendation is appropriate given the uncertainty and the need to observe the execution of the AI strategy and financial performance over subsequent periods.

Keywords

Corvex, Inc., SEC Filing, 10-Q, Quarterly Report, AI Cloud Computing, GPU Infrastructure, Merger, Financial Results, Wearable Health, Connected Devices